Connection
Marilyn Manco-Johnson to Female
This is a "connection" page, showing publications Marilyn Manco-Johnson has written about Female.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.630 |
|
|
|
-
Warren BB, Thornhill D, Singer-Fox L, Smith J, Funk S, Manco-Johnson M. Haemophilia Joint Health Score Ranges Across the Lifespan: Variation by Haemophilia Type and Severity. Haemophilia. 2026 Jul-Aug; 32(4):1016-1024.
Score: 0.033
-
Manco-Johnson M, Brons P, Knoebl P, Wang M, Siffel C, Turecek PL, Gazda HT. Real-world use of protein C concentrate for the treatment of patients with protein C deficiency: an international registry. J Thromb Haemost. 2025 11; 23(11):3569-3577.
Score: 0.032
-
Warren BB, Moyer GC, Manco-Johnson MJ. Hemostasis in the Pregnant Woman, the Placenta, the Fetus, and the Newborn Infant. Semin Thromb Hemost. 2023 Jun; 49(4):319-329.
Score: 0.027
-
Smith J, Thornhill D, Goldenberg NA, Brandão L, Knapp-Clevenger R, Warren BB, Sung L, Kahn SR, Manco-Johnson M. Validation of Outcome Instruments for Pediatric Postthrombotic Syndrome: Introducing the Peds-VEINES-QOL, a New Health-Related Quality of Life Instrument. Thromb Haemost. 2021 Oct; 121(10):1367-1375.
Score: 0.023
-
Rajpurkar M, Forsyth A, Manco-Johnson M. Current challenges for men and women with mild-to-moderate haemophilia. Haemophilia. 2021 Jan; 27 Suppl 1:5-7.
Score: 0.023
-
Manco-Johnson MJ, Byams VR, Recht M, Dudley B, Dupervil B, Aschman DJ, Oakley M, Kapica S, Voutsis M, Humes S, Kulkarni R, Grant AM. Community counts: Evolution of a national surveillance system for bleeding disorders. Am J Hematol. 2018 06; 93(6):E137-E140.
Score: 0.019
-
Manco-Johnson MJ, Bomgaars L, Palascak J, Shapiro A, Geil J, Fritsch S, Pavlova BG, Gelmont D. Efficacy and safety of protein C concentrate to treat purpura fulminans and thromboembolic events in severe congenital protein C deficiency. Thromb Haemost. 2016 07 04; 116(1):58-68.
Score: 0.017
-
Branchford BR, Ruegg K, Villalobos-Menuey E, Jacobson LJ, Di Paola JA, Manco-Johnson M. FVIII/VWF ratio is not a reliable predictor of VWD in children. Pediatr Blood Cancer. 2014 May; 61(5):936-9.
Score: 0.014
-
Joachim E, Goldenberg NA, Bernard TJ, Armstrong-Wells J, Stabler S, Manco-Johnson MJ. The methylenetetrahydrofolate reductase polymorphism (MTHFR c.677C>T) and elevated plasma homocysteine levels in a U.S. pediatric population with incident thromboembolism. Thromb Res. 2013 Aug; 132(2):170-4.
Score: 0.014
-
Goldenberg NA, Bernard TJ, Hillhouse J, Armstrong-Wells J, Galinkin J, Knapp-Clevenger R, Jacobson L, Marcovina SM, Manco-Johnson MJ. Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children. Haematologica. 2013 May; 98(5):802-7.
Score: 0.013
-
Manco-Johnson MJ, Wang M, Goldenberg NA, Soep J, Gibson E, Knoll CM, Mourani PM. Treatment, survival, and thromboembolic outcomes of thrombotic storm in children. J Pediatr. 2012 Oct; 161(4):682-8.e1.
Score: 0.013
-
Bornikova L, Peyvandi F, Allen G, Bernstein J, Manco-Johnson MJ. Fibrinogen replacement therapy for congenital fibrinogen deficiency. J Thromb Haemost. 2011 Sep; 9(9):1687-704.
Score: 0.012
-
Gill JC, Shapiro A, Valentino LA, Bernstein J, Friedman C, Nichols WL, Manco-Johnson M. von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease. Haemophilia. 2011 Nov; 17(6):895-905.
Score: 0.012
-
Goldenberg NA, Branchford B, Wang M, Ray C, Durham JD, Manco-Johnson MJ. Percutaneous mechanical and pharmacomechanical thrombolysis for occlusive deep vein thrombosis of the proximal limb in adolescent subjects: findings from an institution-based prospective inception cohort study of pediatric venous thromboembolism. J Vasc Interv Radiol. 2011 Feb; 22(2):121-32.
Score: 0.012
-
Goldenberg NA, Donadini MP, Kahn SR, Crowther M, Kenet G, Nowak-Göttl U, Manco-Johnson MJ. Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica. 2010 Nov; 95(11):1952-9.
Score: 0.011
-
Manco-Johnson MJ. Advances in the care and treatment of children with hemophilia. Adv Pediatr. 2010; 57(1):287-94.
Score: 0.011
-
Manco-Johnson MJ, Dimichele D, Castaman G, Fremann S, Knaub S, Kalina U, Peyvandi F, Piseddu G, Mannucci P. Pharmacokinetics and safety of fibrinogen concentrate. J Thromb Haemost. 2009 Dec; 7(12):2064-9.
Score: 0.011
-
Manco-Johnson MJ, Hacker MR, Jacobson LJ, Hay WW. Pharmacokinetics of protein C and antithrombin in the fetal lamb: a model to predict human neonatal replacement dosing. Neonatology. 2009; 95(4):279-85.
Score: 0.010
-
Goldenberg NA, Manco-Johnson MJ. Protein C deficiency. Haemophilia. 2008 Nov; 14(6):1214-21.
Score: 0.010
-
Goldenberg NA, Durham JD, Knapp-Clevenger R, Manco-Johnson MJ. A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children. Blood. 2007 Jul 01; 110(1):45-53.
Score: 0.009
-
Hacker MR, Primeaux J, Manco-Johnson MJ. A patient satisfaction survey for haemophilia treatment centres. Haemophilia. 2006 Mar; 12(2):163-8.
Score: 0.008
-
Manco-Johnson MJ. Postthrombotic syndrome in children. Acta Haematol. 2006; 115(3-4):207-13.
Score: 0.008
-
Goldenberg NA, Jacobson L, Manco-Johnson MJ. Brief communication: duration of platelet dysfunction after a 7-day course of Ibuprofen. Ann Intern Med. 2005 Apr 05; 142(7):506-9.
Score: 0.008
-
Manco-Johnson MJ. Risk of stratified therapies for antiphospholipid antibody syndrome (APS) in pregnancy: is tailored treatment ready for prime time? J Thromb Haemost. 2005 Feb; 3(2):240-2.
Score: 0.008
-
Manco-Johnson MJ. Development of hemostasis in the fetus. Thromb Res. 2005 Feb; 115 Suppl 1:55-63.
Score: 0.008
-
Goldenberg NA, Hathaway WE, Jacobson L, Manco-Johnson MJ. A new global assay of coagulation and fibrinolysis. Thromb Res. 2005; 116(4):345-56.
Score: 0.008
-
Goldenberg NA, Schulman S, Kittelson JM, Abshire TC, Casella JF, Dale R, Halperin JL, Hanson J, Kessler CM, Manco-Johnson MJ, McDevitt L, Sidonio RF, Spyropoulos AC, Steg PG, Bonaca MP. Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years. J Thromb Haemost. 2025 02; 23(2):651-656.
Score: 0.008
-
Herzog E, Zavaletta V, Katz D, Lindquist J, Manco-Johnson M, Schardt T, Annam A. Interventional Treatment of Pediatric Venous Thromboembolic Disease. Tech Vasc Interv Radiol. 2024 Jun; 27(2):100957.
Score: 0.007
-
Han JH, Dupervil B, Mahajerin A, Kulkarni R, Manco-Johnson M, Thornburg C. Clinical and treatment characteristics of infants and toddlers less than 2 years of age with hemophilia. Blood Adv. 2024 06 11; 8(11):2707-2717.
Score: 0.007
-
Moreira DC, Garrido C, Rosado R, Girón V, Letona T, Morales G, Valverde P, Velásquez T, Alfaro J, Orellana E, Ortega MA, Salguero P, Fox Irwin L, Andujar A, de Alarcón PA, Luna-Fineman S, Manco-Johnson M, Conter V, Verna M, Canesi M, Massimino M, Spreafico F, Ferrari A, Gassant PY, Vásquez R, Friedrich P, Mack R, Ribeiro R, Metzger ML, Rodriguez-Galindo C, Antillón-Klussmann F. Impact of a Regional Pediatric Hematology/Oncology Fellowship Program in Guatemala. JCO Glob Oncol. 2024 06; 10:e2300474.
Score: 0.007
-
Casini A, Abdul Kadir R, Abdelwahab M, Manco-Johnson MJ, Raut S, Ross C, de Moerloose P, Santoro C, Acharya S. Management of pregnancy and delivery in congenital fibrinogen disorders: communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen. J Thromb Haemost. 2024 05; 22(5):1516-1521.
Score: 0.007
-
Manco-Johnson MJ, Knapp-Clevenger R. Activated protein C concentrate reverses purpura fulminans in severe genetic protein C deficiency. J Pediatr Hematol Oncol. 2004 Jan; 26(1):25-7.
Score: 0.007
-
Petäjä J, Manco-Johnson MJ. Protein C pathway in infants and children. Semin Thromb Hemost. 2003 Aug; 29(4):349-62.
Score: 0.007
-
Smith AA, Jacobson LJ, Miller BI, Hathaway WE, Manco-Johnson MJ. A new euglobulin clot lysis assay for global fibrinolysis. Thromb Res. 2003; 112(5-6):329-37.
Score: 0.007
-
Manco-Johnson MJ, Jacobson LJ, Hacker MR, Townsend SF, Murphy J, Hay W. Development of coagulation regulatory proteins in the fetal and neonatal lamb. Pediatr Res. 2002 Oct; 52(4):580-8.
Score: 0.007
-
Manco-Johnson MJ, Nuss R, Lear J, Wiedel J, Geraghty SJ, Hacker MR, Funk S, Kilcoyne RF, Murphy J. 32P Radiosynoviorthesis in children with hemophilia. J Pediatr Hematol Oncol. 2002 Oct; 24(7):534-9.
Score: 0.007
-
Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA, Halperin JL, Hamblin F, Kessler CM, Manco-Johnson MJ, Sidonio RF, Spyropoulos AC, Steg PG, Turpie AGG, Schulman S. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial. JAMA. 2022 01 11; 327(2):129-137.
Score: 0.006
-
Josephson C, Nuss R, Jacobson L, Hacker MR, Murphy J, Weinberg A, Manco-Johnson MJ. The varicella-autoantibody syndrome. Pediatr Res. 2001 Sep; 50(3):345-52.
Score: 0.006
-
Kuijlaars IAR, van der Net J, Feldman BM, Aspdahl M, Bladen M, de Boer W, Cuesta-Barriuso R, Matlary RED, Funk SM, Hilliard P, John JA, Kempton CL, de Kleijn P, Manco-Johnson M, Petrini P, Poonnoose P, St-Louis J, Thomas S, Timmer MA, Trakymiene SS, van Vlimmeren L, Fischer K. Evaluating international Haemophilia Joint Health Score (HJHS) results combined with expert opinion: Options for a shorter HJHS. Haemophilia. 2020 Nov; 26(6):1072-1080.
Score: 0.006
-
Maher KN, Gibson E, Warren BB, Funk SM, Shearer R, Buckner TW, Wang M, Manco-Johnson MJ, Ng CJ. Prophylaxis for children with moderate hemophilia: Use of a guideline to increase early initiation. Pediatr Blood Cancer. 2021 01; 68(1):e28577.
Score: 0.006
-
Slatnick LR, Thornhill D, Deakyne Davies SJ, Ford JB, Scott HF, Manco-Johnson MJ, Warren BB. Disseminated Intravascular Coagulation Is an Independent Predictor of Adverse Outcomes in Children in the Emergency Department with Suspected Sepsis. J Pediatr. 2020 10; 225:198-206.e2.
Score: 0.006
-
Manco-Johnson MJ, Nuss R, Hays T, Krupski W, Drose J, Manco-Johnson ML. Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatr. 2000 Apr; 136(4):446-53.
Score: 0.005
-
Warren BB, Jacobson L, Kempton C, Buchanan GR, Recht M, Brown D, Leissinger C, Shapiro AD, Abshire TC, Manco-Johnson MJ. Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes. Haemophilia. 2019 Sep; 25(5):867-875.
Score: 0.005
-
Kim JS, Kaufman J, Patel SS, Manco-Johnson M, Di Paola J, da Cruz EM. Antiplatelet Effect of Ketorolac in Children After Congenital Cardiac Surgery. World J Pediatr Congenit Heart Surg. 2018 11; 9(6):651-658.
Score: 0.005
-
Sood SL, Cheng D, Ragni M, Kessler CM, Quon D, Shapiro AD, Key NS, Manco-Johnson MJ, Cuker A, Kempton C, Wang TF, Eyster ME, Kuriakose P, von Drygalski A, Gill JC, Wheeler A, Kouides P, Escobar MA, Leissinger C, Galdzicka S, Corson M, Watson C, Konkle BA. A cross-sectional analysis of cardiovascular disease in the hemophilia population. Blood Adv. 2018 06 12; 2(11):1325-1333.
Score: 0.005
-
Ross C, Rangarajan S, Karimi M, Toogeh G, Apte S, Lissitchkov T, Acharya S, Manco-Johnson MJ, Srivastava A, Brand B, Schwartz BA, Knaub S, Peyvandi F. Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency. J Thromb Haemost. 2018 02; 16(2):253-261.
Score: 0.005
-
Sifontes MT, Nuss R, Hunger SP, Waters J, Jacobson LJ, Manco-Johnson M. Activated protein C resistance and the factor V Leiden mutation in children with thrombosis. Am J Hematol. 1998 Jan; 57(1):29-32.
Score: 0.005
-
Nuytemans K, Ortel TL, Gomez L, Hofmann N, Alves N, Dueker N, Beecham A, Whitehead P, Hahn Estabrooks S, Kitchens CS, Erkan D, Brandão LR, James AH, Kulkarni R, Manco-Johnson MJ, Pericak-Vance MA, Vance JM. Variants in chondroitin sulfate metabolism genes in thrombotic storm. Thromb Res. 2018 01; 161:43-51.
Score: 0.005
-
Andersson NG, Auerswald G, Barnes C, Carcao M, Dunn AL, Fijnvandraat K, Hoffmann M, Kavakli K, Kenet G, Kobelt R, Kurnik K, Liesner R, Mäkipernaa A, Manco-Johnson MJ, Mancuso ME, Molinari AC, Nolan B, Perez Garrido R, Petrini P, Platokouki HE, Shapiro AD, Wu R, Ljung R. Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment. Br J Haematol. 2017 10; 179(2):298-307.
Score: 0.005
-
Manco-Johnson MJ. Disorders of hemostasis in childhood: risk factors for venous thromboembolism. Thromb Haemost. 1997 Jul; 78(1):710-4.
Score: 0.005
-
Sifontes MT, Nuss R, Hunger SP, Wilimas J, Jacobson LJ, Manco-Johnson MJ. The factor V Leiden mutation in children with cancer and thrombosis. Br J Haematol. 1997 Mar; 96(3):484-9.
Score: 0.004
-
Kulkarni R, Presley RJ, Lusher JM, Shapiro AD, Gill JC, Manco-Johnson M, Koerper MA, Abshire TC, DiMichele D, Hoots WK, Mathew P, Nugent DJ, Geraghty S, Evatt BL, Soucie JM. Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System. Haemophilia. 2017 Mar; 23(2):207-214.
Score: 0.004
-
Manco-Johnson MJ, Nuss R, Key N, Moertel C, Jacobson L, Meech S, Weinberg A, Lefkowitz J. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr. 1996 Mar; 128(3):319-23.
Score: 0.004
-
Sifontes MT, Nuss R, Jacobson LJ, Griffin JH, Manco-Johnson MJ. Thrombosis in otherwise well children with the factor V Leiden mutation. J Pediatr. 1996 Mar; 128(3):324-8.
Score: 0.004
-
Flood VH, Christopherson PA, Gill JC, Friedman KD, Haberichter SL, Bellissimo DB, Udani RA, Dasgupta M, Hoffmann RG, Ragni MV, Shapiro AD, Lusher JM, Lentz SR, Abshire TC, Leissinger C, Hoots WK, Manco-Johnson MJ, Gruppo RA, Boggio LN, Montgomery KT, Goodeve AC, James PD, Lillicrap D, Peake IR, Montgomery RR. Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States. Blood. 2016 05 19; 127(20):2481-8.
Score: 0.004
-
Antun A, Monahan PE, Manco-Johnson MJ, Callaghan MU, Kanin M, Knoll C, Carpenter SL, Davis JA, Guerrera MF, Kruse-Jarres R, Ragni MV, Witmer C, McCracken CE, Kempton CL. Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study. J Thromb Haemost. 2015 Nov; 13(11):1980-8.
Score: 0.004
-
Goldenberg NA, Abshire T, Blatchford PJ, Fenton LZ, Halperin JL, Hiatt WR, Kessler CM, Kittelson JM, Manco-Johnson MJ, Spyropoulos AC, Steg PG, Stence NV, Turpie AG, Schulman S. Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings. J Thromb Haemost. 2015 Sep; 13(9):1597-605.
Score: 0.004
-
Nuss R, Hays T, Manco-Johnson M. Childhood thrombosis. Pediatrics. 1995 Aug; 96(2 Pt 1):291-4.
Score: 0.004
-
Faiz AS, Khan I, Beckman MG, Bockenstedt P, Heit JA, Kulkarni R, Manco-Johnson M, Moll S, Ortel TL, Philipp CS. Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism. Thromb Res. 2015 Sep; 136(3):535-41.
Score: 0.004
-
Manco-Johnson MJ, Spedale S, Peters M, Townsend SF, Jacobson LJ, Christian J, Krugman SD, Hay WW, Sparks JW. Identification of a unique form of protein C in the ovine fetus: developmentally linked transition to the adult form. Pediatr Res. 1995 Mar; 37(3):365-72.
Score: 0.004
-
Lewis DA, Suchindran S, Beckman MG, Hooper WC, Grant AM, Heit JA, Manco-Johnson M, Moll S, Philipp CS, Kenney K, De Staercke C, Pyle ME, Chi JT, Ortel TL. Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism. Thromb Res. 2015 Apr; 135(4):659-65.
Score: 0.004
-
Armstrong-Wells J, Donnelly M, Post MD, Manco-Johnson MJ, Winn VD, Sébire G. Inflammatory predictors of neurologic disability after preterm premature rupture of membranes. Am J Obstet Gynecol. 2015 Feb; 212(2):212.e1-9.
Score: 0.004
-
Manco-Johnson MJ, Carver T, Jacobson LJ, Townsend SF, Hay WW. Hyperglycemia-induced hyperinsulinemia decreases maternal and fetal plasma protein C concentration during ovine gestation. Pediatr Res. 1994 Sep; 36(3):293-9.
Score: 0.004
-
Soucie JM, Miller CH, Kelly FM, Payne AB, Creary M, Bockenstedt PL, Kempton CL, Manco-Johnson MJ, Neff AT. A study of prospective surveillance for inhibitors among persons with haemophilia in the United States. Haemophilia. 2014 Mar; 20(2):230-7.
Score: 0.004
-
Philipp CS, Faiz AS, Beckman MG, Grant A, Bockenstedt PL, Heit JA, James AH, Kulkarni R, Manco-Johnson MJ, Moll S, Ortel TL. Differences in thrombotic risk factors in black and white women with adverse pregnancy outcome. Thromb Res. 2014 Jan; 133(1):108-11.
Score: 0.004
-
Landi D, Beckman MG, Shah NR, Bockenstedt P, Grant AM, Heit JA, Key NS, Kulkarni R, Manco-Johnson M, Moll S, Philipp CS, Andersen JC, Ortel TL. Characteristics of abdominal vein thrombosis in children and adults. Thromb Haemost. 2013 Apr; 109(4):625-32.
Score: 0.003
-
Neeves KB, Onasoga AA, Hansen RR, Lilly JJ, Venckunaite D, Sumner MB, Irish AT, Brodsky G, Manco-Johnson MJ, Di Paola JA. Sources of variability in platelet accumulation on type 1 fibrillar collagen in microfluidic flow assays. PLoS One. 2013; 8(1):e54680.
Score: 0.003
-
Goldenberg NA, Jenkins S, Jack J, Armstrong-Wells J, Fenton LZ, Stence NV, Oleszek J, Boada R, Wilkening GN, Wilkinson C, Soep JB, Miyamoto SD, Bajaj L, Mourani PM, Manco-Johnson MJ, Bernard TJ. Arteriopathy, D-dimer, and risk of poor neurologic outcome in childhood-onset arterial ischemic stroke. J Pediatr. 2013 May; 162(5):1041-6.e1.
Score: 0.003
-
Hancock HS, Wang M, Gist KM, Gibson E, Miyamoto SD, Mourani PM, Manco-Johnson MJ, Goldenberg NA. Cardiac findings and long-term thromboembolic outcomes following pulmonary embolism in children: a combined retrospective-prospective inception cohort study. Cardiol Young. 2013 Jun; 23(3):344-52.
Score: 0.003
-
Moruf A, Spyropoulos AC, Schardt TQ, Gibson E, Manco-Johnson MJ, Wang M, Goldenberg NA. Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: a pediatric experience. Thromb Res. 2012 Oct; 130(4):612-5.
Score: 0.003
-
Pearson V, Ruzas C, Krebs NF, Goldenberg NA, Manco-Johnson MJ, Bernard TJ. Overweight and obesity are increased in childhood-onset cerebrovascular disease. J Child Neurol. 2013 Apr; 28(4):517-9.
Score: 0.003
-
Bombardier C, Villalobos-Menuey E, Ruegg K, Hathaway WE, Manco-Johnson MJ, Goldenberg NA. Monitoring hypercoagulability and hypofibrinolysis following acute venous Thromboembolism in children: application of the CloFAL assay in a prospective inception cohort study. Thromb Res. 2012 Sep; 130(3):343-9.
Score: 0.003
-
Kedia S, Stence N, Manco-Johnson M, Armstrong-Wells J, Bernard TJ. Late cytotoxic edema in 2 children with hemiplegia: hemiplegic migraine or stroke? Headache. 2012 Apr; 52(4):674-8.
Score: 0.003
-
Branchford BR, Mourani P, Bajaj L, Manco-Johnson M, Wang M, Goldenberg NA. Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validation. Haematologica. 2012 Apr; 97(4):509-15.
Score: 0.003
-
Di Paola J, Lethagen S, Gill J, Mannucci P, Manco-Johnson M, Bernstein J, Nichols WL, Bergman GE. Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand's disease (VWD) has limited value in dosing for surgery. Haemophilia. 2011 Sep; 17(5):752-8.
Score: 0.003
-
Calhoon MJ, Ross CN, Pounder E, Cassidy D, Manco-Johnson MJ, Goldenberg NA. High prevalence of thrombophilic traits in children with family history of thromboembolism. J Pediatr. 2010 Sep; 157(3):485-9.
Score: 0.003
-
Bernard TJ, Fenton LZ, Apkon SD, Boada R, Wilkening GN, Wilkinson CC, Soep JB, Miyamoto SD, Tripputi M, Armstrong-Wells J, Benke TA, Manco-Johnson MJ, Goldenberg NA. Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke. J Pediatr. 2010 Apr; 156(4):651-6.
Score: 0.003
-
Greffe BS, Marlar RA, Manco-Johnson MJ. Neonatal protein C: molecular composition and distribution in normal term infants. Thromb Res. 1989 Oct 01; 56(1):91-8.
Score: 0.003
-
Young G, Becker S, Düring C, Friedrichs F, Goldenberg N, Kenet G, Manco-Johnson M, Scheffold C, Nowak-Göttl U. Influence of the factor II G20210A variant or the factor V G1691A mutation on symptomatic recurrent venous thromboembolism in children: an international multicenter cohort study. J Thromb Haemost. 2009 Jan; 7(1):72-9.
Score: 0.002
-
Manco-Johnson MJ, Marlar RA, Jacobson LJ, Hays T, Warady BA. Severe protein C deficiency in newborn infants. J Pediatr. 1988 Aug; 113(2):359-63.
Score: 0.002
-
Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med. 2004 Sep 09; 351(11):1081-8.
Score: 0.002
-
Wang M, Hays T, Balasa V, Bagatell R, Gruppo R, Grabowski EF, Valentino LA, Tsao-Wu G, Manco-Johnson MJ. Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol. 2003 May; 25(5):379-86.
Score: 0.002
-
Young G, Manco-Johnson M, Gill JC, Dimichele DM, Tarantino MD, Abshire T, Nugent DJ. Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study. J Thromb Haemost. 2003 May; 1(5):958-62.
Score: 0.002
-
Brenner BR, Nowak-Göttl U, Kosch A, Manco-Johnson M, Laposata M. Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children. Arch Pathol Lab Med. 2002 Nov; 126(11):1296-303.
Score: 0.002
-
Goedert JJ, Eyster ME, Lederman MM, Mandalaki T, De Moerloose P, White GC, Angiolillo AL, Luban NL, Sherman KE, Manco-Johnson M, Preiss L, Leissinger C, Kessler CM, Cohen AR, DiMichele D, Hilgartner MW, Aledort LM, Kroner BL, Rosenberg PS, Hatzakis A. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood. 2002 Sep 01; 100(5):1584-9.
Score: 0.002
-
Baker DC, Robbe SL, Jacobson L, Manco-Johnson MJ, Holler L, Lefkowitz J. Hereditary deficiency of vitamin-K-dependent coagulation factors in Rambouillet sheep. Blood Coagul Fibrinolysis. 1999 Mar; 10(2):75-80.
Score: 0.001
-
Mahasandana C, Suvatte V, Chuansumrit A, Marlar RA, Manco-Johnson MJ, Jacobson LJ, Hathaway WE. Homozygous protein S deficiency in an infant with purpura fulminans. J Pediatr. 1990 Nov; 117(5):750-3.
Score: 0.001
-
Mahasandana C, Suvatte V, Marlar RA, Manco-Johnson MJ, Jacobson LJ, Hathaway WE. Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet. 1990 Jan 06; 335(8680):61-2.
Score: 0.001
-
Sedman A, Bell P, Manco-Johnson M, Schrier R, Warady BA, Heard EO, Butler-Simon N, Gabow P. Autosomal dominant polycystic kidney disease in childhood: a longitudinal study. Kidney Int. 1987 Apr; 31(4):1000-5.
Score: 0.001
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|